Copyright © 2013 Ji-Fu Wei et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

1. J. Polgár, E. M. Magnenat, M. C. Peitsch, T. N. C. Wells, and K. J. Clemetson, “Asp-49 is not an absolute prerequisite for the enzymic activity of low-$M_{\text{r}}$ phospholipases A₂: purification, characterization and computer modelling of an enzymically active Ser-49 phospholipase A₂, ecarpholin S, from the venom of Echis carinatus sochureki (saw-scaled viper),” Biochemical Journal, vol. 319, no. 3, pp. 961–968, 1996. View at Scopus
2. I. Krizaj, A. L. Bieber, A. Ritonja, and F. Gubensek, “The primary structure of ammodytin L, a myotoxic phospholipase A₂ homologue from Vipera ammodytes venom,” European Journal of Biochemistry, vol. 202, no. 3, pp. 1165–1168, 1991. View at Scopus
3. X. Zhou, T. C. Tan, S. Valiyaveettil et al., “Structural characterization of myotoxic ecarpholin S from Echis carinatus venom,” Biophysical Journal, vol. 95, no. 7, pp. 3366–3380, 2008. View at Publisher · View at Google Scholar · View at Scopus
4. I. H. Tsai, Y. M. Wang, Y. H. Chen, T. S. Tsai, and M. C. Tu, “Venom phospholipases A₂ of bamboo viper (Trimeresurus stejnegeri): molecular characterization, geographic variations and evidence of multiple ancestries,” Biochemical Journal, vol. 377, no. 1, pp. 215–223, 2004. View at Publisher · View at Google Scholar · View at Scopus
5. J. F. Wei, X. L. Wei, Q. Y. Chen et al., “N49 phospholipase A₂, a unique subgroup of snake venom group II phospholipase A₂,” Biochimica et Biophysica Acta, vol. 1760, no. 3, pp. 462–471, 2006. View at Publisher · View at Google Scholar · View at Scopus
6. T. Chijiwa, E. Tokunaga, R. Ikeda et al., “Discovery of novel [Arg⁴⁹]phospholipase A₂ isozymes from Protobothrops elegans venom and regional evolution of Crotalinae snake venom phospholipase A₂ isozymes in the Southwestern islands of Japan and Taiwan,” Toxicon, vol. 48, no. 6, pp. 672–682, 2006. View at Publisher · View at Google Scholar · View at Scopus
7. D. Mebs, U. Kuch, F. I. V. Coronas, C. V. F. Batista, A. Gumprecht, and L. D. Possani, “Biochemical and biological activities of the venom of the Chinese pitviper Zhaoermia mangshanensis, with the complete amino acid sequence and phylogenetic analysis of a novel Arg49 phospholipase A₂ myotoxin,” Toxicon, vol. 47, no. 7, pp. 797–811, 2006. View at Publisher · View at Google Scholar · View at Scopus
8. J. F. Wei, T. Li, X. L. Wei et al., “Purification, characterization and cytokine release function of a novel Arg-49 phospholipase A₂ from the venom of Protobothrops mucrosquamatus,” Biochimie, vol. 88, no. 10, pp. 1331–1342, 2006. View at Publisher · View at Google Scholar · View at Scopus
9. Q. M. Lu, Y. Jin, J. F. Wei et al., “Characterization and cloning of a novel phospholipase A₂ from the venom of Trimeresurus jerdonii snake,” Toxicon, vol. 40, no. 9, pp. 1313–1319, 2002. View at Publisher · View at Google Scholar · View at Scopus
10. Q. M. Lu, Y. Jin, J. F. Wei, W. Y. Wang, and Y. L. Xiong, “Biochemical and biological properties of Trimeresurus jerdonii venom and characterization of a platelet aggregation-inhibiting acidic phospholipase A₂,” Journal of Natural Toxins, vol. 11, no. 1, pp. 25–33, 2002. View at Scopus
11. R. M. Kini, “Structure-function relationships and mechanism of anticoagulant phospholipase A₂ enzymes from snake venoms,” Toxicon, vol. 45, no. 8, pp. 1147–1161, 2005. View at Publisher · View at Google Scholar · View at Scopus
12. I. H. Tsai, P. J. Lu, Y. M. Wang, C. L. Ho, and L. L. Liaw, “Molecular cloning and characterization of a neurotoxic phospholipase A₂ from the venom of Taiwan habu (Trimeresurus mucrosquamatus),” Biochemical Journal, vol. 311, no. 3, pp. 895–900, 1995. View at Scopus
13. A. M. Soares, R. Guerra-Sá, C. R. Borja-Oliveira et al., “Structural and functional characterization of BnSP-7, a Lys49 myotoxic phospholipase A₂ homologue from Bothrops neuwiedi pauloensis venom,” Archives of Biochemistry and Biophysics, vol. 378, no. 2, pp. 201–209, 2000. View at Publisher · View at Google Scholar · View at Scopus
14. A. M. Soares, S. H. Andrião-Escarso, Y. Angulo et al., “Structural and functional characterization of myotoxin I, a Lys49 phospholipase A₂ homologue from Bothrops moojeni (Caissaca) snake venom,” Archives of Biochemistry and Biophysics, vol. 373, no. 1, pp. 7–15, 2000. View at Publisher · View at Google Scholar · View at Scopus
15. M. M. Kanashiro, R. de Cássia M Escocard, J. H. Petretski et al., “Biochemical and biological properties of phospholipases A₂ from Bothrops atrox snake venom,” Biochemical Pharmacology, vol. 64, no. 7, pp. 1179–1186, 2002. View at Publisher · View at Google Scholar · View at Scopus
16. S. Lloret and J. J. Moreno, “Oedema formation and degranulation of mast cells by phospholipase A₂ purified from porcine pancreas and snake venoms,” Toxicon, vol. 31, no. 8, pp. 949–956, 1993. View at Publisher · View at Google Scholar · View at Scopus
17. E. C. T. Landucci, R. C. de Castro, M. Toyama et al., “Inflammatory oedema induced by the Lys-49 phospholipase A₂ homologue piratoxin-i in the rat and rabbit: effect of polyanions and p-bromophenacyl bromide,” Biochemical Pharmacology, vol. 59, no. 10, pp. 1289–1294, 2000. View at Publisher · View at Google Scholar · View at Scopus
18. C. F. P. Teixeira, E. C. T. Landucci, E. Antunes, M. Chacur, and Y. Cury, “Inflammatory effects of snake venom myotoxic phospholipases A₂,” Toxicon, vol. 42, no. 8, pp. 947–962, 2003. View at Publisher · View at Google Scholar · View at Scopus
19. J. P. Zuliani, J. M. Gutiérrez, L. L. Casais e Silva, S. C. Sampaio, B. Lomonte, and C. D. F. Pereira Teixeira, “Activation of cellular functions in macrophages by venom secretory Asp-49 and Lys-49 phospholipases A₂,” Toxicon, vol. 46, no. 5, pp. 523–532, 2005. View at Publisher · View at Google Scholar · View at Scopus
20. E. C. T. Landucci, R. C. Castro, M. F. Pereira et al., “Mast cell degranulation induced by two phospholipase A₂ homologues: dissociation between enzymatic and biological activities,” European Journal of Pharmacology, vol. 343, no. 2-3, pp. 257–263, 1998. View at Publisher · View at Google Scholar · View at Scopus
21. M. Metz, A. M. Piliponsky, C. C. Chan et al., “Mast cells can enhance resistance to snake and honeybee venoms,” Science, vol. 313, no. 5786, pp. 526–530, 2006. View at Publisher · View at Google Scholar · View at Scopus
22. L. A. Schneider, S. M. Schlenner, T. B. Feyerabend, M. Wunderlin, and H. R. Rodewald, “Molecular mechanism of mast cell-mediated innate defense against endothelin and snake venom sarafotoxin,” Journal of Experimental Medicine, vol. 204, no. 11, pp. 2629–2639, 2007. View at Publisher · View at Google Scholar · View at Scopus
23. J. F. Wei, X. L. Wei, Y. Z. Mo, and S. H. He, “Induction of mast cell accumulation, histamine release and skin edema by N49 phospholipase A₂,” BMC Immunology, vol. 10, article 21, 2009. View at Publisher · View at Google Scholar · View at Scopus
24. J. F. Wei, X. L. Wei, Y. Z. Mo, and S. H. He, “Induction of microvascular leakage and histamine release by promutoxin, an Arg49 phospholipase A₂,” Toxicon, vol. 55, no. 4, pp. 888–896, 2010. View at Scopus
25. J. F. Wei, X. L. Wei, Q. Y. Chen, and S. H. He, “Induction of inflammatory cell accumulation by TM-N49 and promutoxin, two novel phospholipase A₂,” Toxicon, vol. 56, no. 4, pp. 580–588, 2010. View at Publisher · View at Google Scholar · View at Scopus
26. K. Ishimaru, H. Kihara, and M. Ohno, “Purification and properties of phospholipase A₂ from venom of Trimeresurus flavoviridis (Habu snake),” Journal of Biochemistry, vol. 88, no. 2, pp. 443–451, 1980. View at Scopus
27. A. L. de Araújo and F. Radvanyi, “Determination of phospholipase A₂ activity by a colorimetric assay using a pH indicator,” Toxicon, vol. 25, no. 11, pp. 1181–1188, 1987. View at Scopus
28. C. A. Thomas, F. J. Yost Jr., R. Snyderman, et al., “Cellular serine proteinase induces chemotaxis by complement activation,” Nature, vol. 269, no. 5628, pp. 521–522, 1977. View at Scopus
29. C. M. Fernandes, S. R. Zamuner, J. P. Zuliani, A. Rucavado, J. M. Gutiérrez, and C. F. Teixeira, “Inflammatory effects of BaP1 a metalloproteinase isolated from Bothrops asper snake venom: leukocyte recruitment and release of cytokines,” Toxicon, vol. 47, no. 5, pp. 549–559, 2006. View at Publisher · View at Google Scholar · View at Scopus
30. S. R. Zamuner, J. P. Zuliani, C. M. Fernandes, J. M. Gutiérrez, and C. F. Teixeira, “Inflammation induced by Bothrops asper venom: release of proinflammatory cytokines and eicosanoids, and role of adhesion molecules in leukocyte infiltration,” Toxicon, vol. 46, no. 7, pp. 806–813, 2005. View at Publisher · View at Google Scholar · View at Scopus
31. J. P. Zuliani, C. M. Fernandes, S. R. Zamuner, J. M. Gutiérrez, and C. F. Teixeira, “Inflammatory events induced by Lys-49 and Asp-49 phospholipases A₂ isolated from Bothrops asper snake venom: role of catalytic activity,” Toxicon, vol. 45, no. 3, pp. 335–346, 2005. View at Publisher · View at Google Scholar · View at Scopus
32. A. Takahara, A. Sugiyama, Y. Satoh, and K. Hashimoto, “Comparison of four rate-correction algorisms for the ventricular repolarization period in assessing net effects of IKr blockers in dogs,” Journal of Pharmacological Sciences, vol. 102, no. 4, pp. 396–404, 2006. View at Publisher · View at Google Scholar · View at Scopus
33. A. Takahara, A. Sugiyama, and K. Hashimoto, “Reduction of repolarization reserve by halothane anaesthesia sensitizes the guinea-pig heart for drug-induced QT interval prolongation,” British Journal of Pharmacology, vol. 146, no. 4, pp. 561–567, 2005. View at Publisher · View at Google Scholar · View at Scopus
34. I. A. Desouza and G. Ribeiro-DaSilva, “The pharmacological profile of mouse hind paw inflammation induced by staphylococcal enterotoxin type A,” Inflammation Research, vol. 46, no. 9, pp. 361–365, 1997. View at Publisher · View at Google Scholar · View at Scopus
35. B. G. Southorn and R. M. Palmer, “Inhibitors of phospholipase A₂ block the stimulation of protein synthesis by insulin in L6 myoblasts,” Biochemical Journal, vol. 270, no. 3, pp. 737–739, 1990. View at Scopus
36. S. He, M. D. A. Gaça, and A. F. Walls, “A role for tryptase in the activation of human mast cells: modulation of histamine release by tryptase and inhibitors of tryptase,” Journal of Pharmacology and Experimental Therapeutics, vol. 286, no. 1, pp. 289–297, 1998. View at Scopus
37. S. He, M. D. A. Gaça, A. R. McEuen, and A. F. Walls, “Inhibitors of chymase as mast cell-stabilizing agents: contribution of chymase in the activation of human mast cells,” Journal of Pharmacology and Experimental Therapeutics, vol. 291, no. 2, pp. 517–523, 1999. View at Scopus
38. G. Lisignoli, S. Toneguzzi, A. Piacentini et al., “Recruitment and proliferation of T lymphocytes is supported by IFNγ- and TNFα-activated human osteoblasts: involvement of CD54 (ICAM-1) and CD106 (VCAM-1) adhesion molecules and CXCR3 chemokine receptor,” Journal of Cellular Physiology, vol. 198, no. 3, pp. 388–398, 2004. View at Publisher · View at Google Scholar · View at Scopus
39. C. Duplàa, T. Couffinhal, L. Labat et al., “Monocyte/macrophage recruitment and expression of endothelial adhesion proteins in human atherosclerotic lesions,” Atherosclerosis, vol. 121, no. 2, pp. 253–266, 1996. View at Publisher · View at Google Scholar · View at Scopus
40. M. Ebisawa, B. S. Bochner, S. N. Georas, and R. P. Schleimer, “Eosinophil transendothelial migration induced by cytokines. I. Role of endothelial and eosinophil adhesion molecules in IL-1β-induced transendothelial migration,” The Journal of Immunology, vol. 149, no. 12, pp. 4021–4028, 1992. View at Scopus
41. E. Forbes, M. Hulet, R. Ahrens, et al., “ICAM-1-dependent pathways regulate colonic eosinophilic inflammation,” Journal of Leukocyte Biology, vol. 80, no. 2, pp. 330–341, 2006. View at Publisher · View at Google Scholar